Citation Impact
Citing Papers
Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology
2011
The phenomenology and treatment of interferon-induced depression
2004
Tissue-Specific Interferon Alpha Subtype Response to SIV Infection in Brain, Spleen, and Lung
2012
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
A randomized trial of paroxetine to prevent interferon-α-induced depression in patients with hepatitis C
2007
Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism
2016 Standout
Inflammation, Sanitation, and Consternation
2010
SUICIDAL IDEATION IS ASSOCIATED WITH ELEVATED INFLAMMATION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
2013
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Hepatitis C Treatment for People With Severe Mental Illness
2006
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder
2009
Cancer Statistics, 2021
2021 Standout
Treatment predictors of a sustained virologic response in hepatitis B and C
2008
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Early prediction of major depression in chronic hepatitis C patients during peg-interferon α-2b treatment by assessment of vegetative-depressive symptoms after four weeks
2007
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Psychiatric and Substance Use Disorders in Individuals with Hepatitis C
2006
Toward an Anti-Inflammatory Strategy for Depression
2011
Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease
2008
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups
2003
Neuropsychiatric Adverse Effects of Interferon-??
2005
Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders
2008
Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma
2017
Incidence and Mortality of Acute‐on‐Chronic Liver Failure Using Two Definitions in Patients with Compensated Cirrhosis
2019
Nitric oxide involvement in depression during interferon-alpha therapy
2003
Depression following pegylated interferon-alpha: Characteristics and vulnerability
2007
Disgust as a disease-avoidance mechanism.
2009 Standout
COVID-19: A promising cure for the global panic
2020 Standout
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Dysregulated relationship of inflammation and oxidative stress in major depression
2012
How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting
2014
Rational HCC screening approaches for patients with NAFLD
2021
Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs
2013
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
2016
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
MAGMA: Generalized Gene-Set Analysis of GWAS Data
2015 Standout
Direct-acting antiviral agents for HCV infection affecting people who inject drugs
2017
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
IDO and interferon-α-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity
2004
Chronic hepatitis B
2007 Standout
Treating hepatitis C in methadone maintenance patients: an interim analysis
2002
Chronic hepatitis B: Update 2009 #
2009 Standout
Is It Justifiable to Withhold Treatment for Hepatitis C from Illicit-Drug Users?
2001
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
Global burden of liver disease: 2023 update
2023 Standout
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
IFN-Lambda (IFN-λ) Is Expressed in a Tissue-Dependent Fashion and Primarily Acts on Epithelial Cells In Vivo
2008
Lipophagy and liver disease: New perspectives to better understanding and therapy
2017
Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels
2013
A novel program for treating patients with trimorbidity
2013
Hepatocellular carcinoma in Ghana: a retrospective analysis of a tertiary hospital data
2020
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
2018
Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells
2020 StandoutNobel
The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
2007
The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans
2002
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone
2005
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness
2010 Standout
Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies
2009
Epidemiology and surveillance for hepatocellular carcinoma: New trends
2020
Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures
2021
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus
2011
The molecular neurobiology of depression
2008 StandoutNature
Illness-related stigma, mood and adjustment to illness in persons with hepatitis C
2006
Hepatitis C virus infection in USA: an estimate of true prevalence
2011
Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice
2015
Hepatocellular carcinoma
2022 Standout
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
Hepatocellular Carcinoma
2019 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Review: Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis
2010
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
2018
Inflammation as a central mechanism in Alzheimer's disease
2018 Standout
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Understudied populations with hepatitis C
2002
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Screening for Hepatitis C Virus Infection in Adolescents and Adults
2020
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
A review of depression and suicide risk assessment using speech analysis
2015 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Metacognition and clinical psychology: a preliminary framework for research and practice
1999
Mindfulness: A proposed operational definition.
2004 Standout
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
2016 StandoutNobel
The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
2014 StandoutNobel
A review of major Crohn’s disease susceptibility genes and their role in disease pathogenesis
2011
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
2011 Standout
Current and Emerging Tools for Hepatocellular Carcinoma Surveillance
2021
Detailed Computational Study of the Active Site of the Hepatitis C Viral RNA Polymerase to Aid Novel Drug Design
2013 StandoutNobel
Works of Eric Dieperink being referenced
Spectrum of Disease in U.S. Veteran Patients With Hepatitis C
2002
Neuropsychiatric Symptoms Associated With Hepatitis C and Interferon Alpha: A Review
2000
Alcohol Use and Treatment of Hepatitis C Virus: Results of a National Multicenter Study
2006
Outcomes of a Hepatitis C Screening Program at a Large Urban VA Medical Center
2008
Management of Chronic Hepatitis C in Veterans: The Potential of Integrated Care Models
2008
Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography - a randomised study
2013
All-Cause Mortality and Liver-Related Outcomes Following Successful Antiviral Treatment for Chronic Hepatitis C
2014
The Effect of Pegylated Interferon-α2b and Ribavirin on Posttraumatic Stress Disorder Symptoms
2008
Integrated Psychiatric/Medical Care in a Chronic Hepatitis C Clinic: Effect on Antiviral Treatment Evaluation and Outcomes
2006
Suicidal ideation during interferon-α2b and ribavirin treatment of patients with chronic hepatitis C
2004
A Prospective Study of Neuropsychiatric Symptoms Associated With Interferon-α-2b and Ribavirin Therapy for Patients With Chronic Hepatitis C
2003
Influence of psychiatric diagnoses on interferon-alpha treatment for chronic hepatitis C in a veteran population
2001
The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial
2017
Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis
2016
Influence of psychiatric diagnoses on alpha-interferon treatment in a veteran population with chronic hepatitis C
2000